Intracellular compartmentalisation is a significant barrier to the successful nucleocytosolic delivery of biologics.
Introduction.
The scientific method requires the iterative gathering and interpretation of evidence used to test a hypothesis (Wagensberg, 2014) . The careful design of experiments helps mitigate the possibility of the misinterpretation of data and is, consequently, something deserving of a great deal of attention. Reliable interpretation requires an understanding of the tools used during an empirical investigation, and this paper seeks to further characterise some of the uses (and missuses) of Green Fluorescent Protein (GFP), a tool that has had a profound impact upon the world of cell biology, within the context of drug delivery and gene therapy (Wahlfors et al., 2001 ).
GFP and its fluorescent variants (Wachter, 2006) have been widely used since the discovery that a mutation of residue 65 (from serine to threonine), dramatically improved its spectral properties (Heim et al., 1995) . GFP is commonly used as a protein "tag" that has been readily visualised in fixed or live cells either directly, using its intrinsic fluorescence i.e.
"Brainbow" technology (Weissman and Pan, 2015) , or indirectly using antibodies which have been identified via a secondary antibody conjugated to a fluorophore, radioisotope or enzyme (Nakamura et al., 2008) . Here a further investigation into the usefulness of GFP within the context of drug delivery has been undertaken. Four questions pertinent to the use of GFP within various experimental situations have been posed: (1) Are molecules that regulate fusion to a specific compartment (i.e. Rab-or SNARE-GFP fusion proteins) a good choice of marker for that compartment (compartments described in figure 1)? (2) How reliable were GFP-marker overexpression experiments when used to define a given endocytic compartment? (3) Can GST-GFP act as a fluid phase endocytic probe? (4) Was GFP fluorescence a robust indicator of (GFP) protein integrity?
Materials and Methods.
Equipment: The orbital shaker, French Press, centrifuges (RC6 Plus) and microtiter plate reader (Microplate Photometer Multiskan FC) were from ThermoFischer, (Loughbourgh, UK). The mini-PROTEAN tetra cell, minitrans-blot, electrophoretic transfer cell and power supplies were from BioRad (Hemel Hempstead, UK). Fluorescence spectra were measured using a Fluoromax-4 spectrofluorometer (Horiba Scientific, Middlesex, UK). Microscopic images were obtained using either: an Eclipse 90i microscope (Nikon UK Ltd., Surrey, UK) fitted with an Apo60 objective and a DS-Qi1Mc camera or an inverted Zeiss LSM880 fitted with a plan apochromat 63x (numerical aperture 1.40) oil emersion objective, (Carl Zeiss Ltd., Cambridge, UK) both with dedicated software. GST-GFP production and enrichment:
The production and enrichment of glutathione-s-transferase (GST) fused in frame with GFP (GFP-GST) has been previously described (Pettit et al., 2014) . In brief Escherichia coli This culture was used to inoculate 1000 mL of 2xYT (containing 25 µg/mL ampicillin), which was left to incubate for 4 hours at 37 o C shaking at 200 rpm prior to the addition of IPTG to a final concentration of 1 mM. After an additional 4 h incubation, the bacteria were sedimented by centrifugation (6 000 xG for 10 min., at 4 o C). The bacterial pellet was suspended in 10 mL of PBS containing 10x EDTA free COmplete TM protease inhibitor cocktail (Roche, Burgess Hill, UK). The bacterial suspension was then subject to lysis using a French Press set to 1500 psi to avoid the possibility of recombinant protein conformational relaxation (associated with detergent lysis). Sodium azide (final concentration of 0.02 % (w/v)) was then added to the preparation as a bacteriostatic. The GST-GFP protein was then enriched by affinity chromatography using glutathione-conjugated Sepharose 4b (GE Healthcare, Bucks, UK), in accordance with the manufacturer's instructions and characterised using gel electrophoresis, Coomassie staining and Western immunoblotting. Spectroscopic and fluorescence analysis of GST-GFP. Previously spectrophotometric characterisation of GST-GFP determined that a wavelength of 484 nm was optimal for GFP excitation and was in agreement with the literature (Pettit et al., 2014) . Consequently, GST-GFP emission spectra were recorded using an excitation wavelength of 484 nm using a Fluoromax-4 spectrofluorometer (Horiba Scientific, Middlesex, UK). GST-GFP stability and pull-down experiments: Enriched GST-GFP (500 μg) (in PBS) was placed in a sterile Eppendorf tube.
Where a pull-down experiment was performed, glutathione conjugated Sepharose 4b beads (GE Healthcare, Bucks, UK) (200 µl bed volume in PBS) were added to the tube. The specified amount of protease was added to each tube and incubated at 37 o C for the specified time. When performing pull-down experiments the preparation was subject to sedimentation
(1 min., at 14 000 rpm 4 o C) and the emission spectra, or emission at 492 nm, for the supernatant was measured as stated. The pellet was suspended in 1 mL of PBS. Finally, 10 μl of this was then added to 1 mL of Laemmli buffer for analysis Western immunoblotting using a GFP specific polyclonal antibody (Cat No. CAB4211; Invitrogen, Paisley, UK). The emission spectra of the supernatants (after excitation at 484 nm) were recorded, prior to the addition of the Laemmli buffer. Cell culture, microscopy and "pulse-chase" experiments:
Vero cells (ATCC number CCL-81), were cultured as previously described (Dyer et al., 2015) . Purified GST-GFP in PBS was filter sterilised using a 0.2 micron filter (Milipore Ltd, Hertfordshire, UK) and added to cultured cells at a concentration of 1 mg/mL in the presence of 200 µM Leupeptin (Sigma-Aldrich Company Ltd., Dorset, UK). This "pulse" of GST-GFP was added to complete cell culture media and incubated for 4 hours at 37 o C. The cells were then washed three times with fresh sterile PBS and returned to incubate in complete media for an additional 20h at 37 o C in 5% (v/v) CO2. The cells were then washed 3 times in PBS and fixed with either cold methanol or formaldehyde (as noted) and as previously described (Dyer et al., 2013; Dyer et al., 2015) . Immunostaining was performed as previously described Richardson et al., 2008; Dyer et al., 2013; Dyer et al., 2015) using EEA1 (BD Bioscience,) LAMP1 or LAMP2 specific monoclonal antibodies (DHSB hybridoma bank, University of Iowa, USA) as previously described Richardson et al., 2008; Dyer et al., 2015) . Over-expression experiments: were conducted as previously described µg of plasmid per well. The eGFP-Rab5 encoding plasmid has been previously described Roberts et al., 1999) . Where there was no transfection cells were subject to a pulse (4 hours), washed 3 times with PBS and then incubated for a further 20 hours in complete media prior to fixation. Sequence comparisons; were performed using the 
Results.
Sequence comparisons as an indicator of marker viability. When the primary protein sequences of the Rat Sarcoma (Ras)-related in brain (Rab)5 isoforms a, b and c were analysed, a very high level of sequence identity was evident (table 2, i.e. between 81.9 and 87.4 %). Given the antigens used to generate the selection of antibodies to Rab5 documented (table 3) , it was unlikely that the antibodies listed would be specific for a given isoform, given the identity (%) between the antigens used to raise them. The similarity between the various primary protein sequences of isoforms of the Rab6-subfamily (Rab6a, Rab6a', Rab6b, Rab6c
and Rab41) was also striking (table 4, i.e. between 98.6 -61.3% sequence identity). Table 5 describes the antigens used to raise selective commercially available antibodies and further emphasises the capacity for mislabelling specific isoforms of Rab6 using commercially available antibodies. Table 6 describes the levels of protein sequence similarity that result from comparing syntaxin7 and syntaxin12 (also called syntaxin13), which also demonstrated a high level of sequence identity (56.2%).
Over-expressed GFP-fusion proteins as intracellular markers.
In an effort to evaluate the compartmentalisation of transiently expressed eGFP-Rab5a in relation to an endocytosed probe (TxR-WGA), eGFP-Rab5a was expressed in Vero cells. EEA1 has been well documented as a Rab5 binding partner (Simonsen et al., 1998) , which interacts with membrane inositol phosphates (Simonsen et al., 1998) . being denoted by arrows in the inset. These vesicles are of a size, distribution and morphology typical of Vero cells (Dyer et al., 2013; Richardson et al., 2008; . with TxR-WGA (panels e). The expanded vesicular structures positive for both TxR-WGA and eGFP-Rab5a (panel f) were profound. This phenotype has been associated with very high (~50 µg/mL) concentrations of WGA (Dyer et al., 2013) or the constitutively active, GTP locked Rab5 mutant, Rab5:Q79L (Barbieri et al., 1996) . GFP fluorescence as a marker for protein integrity. Figure 3 (panel a) shows the emission spectra of GST-GFP over time and there was no readily quantifiable alteration in emission spectra over the 300min documented. The protease trypsin (~0.5units / 500µg GST-GFP) also had very little effect upon the emission spectra of GST-GFP over 300min (panel b), which was similar to the effect produced by adding proteinase k (10units / 500µg GST-GFP) (panel c). When the integrity of the protein GST-GFP was examined by Western immunoblotting, it was evident that at 5min, both trypsin (~0.5 units / 500µg GST-GFP) and proteinase k (10 units / 500µg GST-GFP) had digested GST-GFP, whereas the negative control (no protease) was stable over 300min. A solution to this impasse i.e. using the spectral properties of GFP to monitor protein integrity, was found by using the GST portion of GST-GFP to bind to glutathione-conjugated Sepharose after protease treatment and, after washing away any nonbound material, assaying for fluorescence emission at 492 nm (figure 3: panel e).
The use of GFP as an endocytic probe. The utility of eGFP as a probe for endocytic capture (i.e. as cargo) was explored (figure 4). The late endocytic marker lysosome associated membrane protein (LAMP)1 has been well-characterised and localises to late endosomes, endolysosomes and lysosomes (Chen et al., 1985) . The anti-LAMP1 and anti-LAMP2
antibodies required the fixation of cells in cold methanol for immunofluorescence work. After
MeOH fixation, little GFP signal was evident (figure 4: panel a) despite the LAMP1 signal being readily detectable (panel b). After fixation using aldehyde, the signal from GST-GFP (panel d) was clearly coincident with that from TxR-bovine serum albumin (BSA) (panel e), which, at 24h, has been reported resident in a late endocytic compartment (panel f) (Richardson et al., 2008) . The data describing the localisation of GST-GFP relative to TxR-BSA (panels d, e and f) appears to be substantiated by those describing the location of GST-GFP (panel g) relative to early endosomal marker EEA1 (panel h) after 24h. Here there appears to be some signal from GFP, however, there was some, but not exclusive localisation between GFP-GST and EEA1. Figure 4 (panel j) highlights another problem with using GFP-GST as a probe. Here, aldehyde fixed cells co-labelled with TxR-WGA, display a marked lack of GFP signal (panel j) relative to a robust TxR-WGA signal (panel k) when examined using an LSM880. This made assessing the level of co-localisation very difficult (panel l).
Discussion.
When interpreting data from single cell assays, a variety of assumptions are often made with regard to the nature of a GFP "tag". The first is that if the GFP molecule has been degraded, then fluorescence output would be reduced accordingly. The second is that a GFP tagged molecule will behave in a way that was representative of the analogue it was being used to mimic. Finally, there remains an assumption that because a molecule has been documented in a specific location, that location is where the molecule in question must function. This final observation is a fallacy, as a molecule will be observed where there is a large pool of the molecule, even a reservoir, which may not necessarily be the place where the molecule functions. However, unpacking this assumption is beyond the scope of this paper. The first and second assumptions are challenged herein by addressing the questions stated in the introduction:
Are molecules that regulate fusion to a specific compartment (i.e. Rab-or SNARE-GFP fusions) a good choice of marker for that compartment? The various Rab5 isoforms documented (table 2) generally have the same intracellular distribution (i.e. to early endocytic compartments) (Chen et al., 2014) . Consequently, the issue of misidentifying a Rab5 isoform would not present a huge problem in terms of mislabelling a specific intracellular compartment. Most intracellular markers occupy more than one intracellular compartment, a specific example being the transferrin receptor, which is often used as a marker for recycling endosomes (i.e. a Rab11 enriched compartment) (Richardson, 2010) . This receptor cycles through early and recycling endosomes en route to the plasma membrane, and back to the early endosome after internalisation. The Rab6 subfamily of proteins is a little more diverse than the various isoforms of Rab5, regulating fusion through the Golgi network (Liu and Storrie, 2015) . However, specific isoforms have demonstrated tissue specific expression.
Rab6b has been found mainly in neuronal cells (Opdam et al., 2000) , and Rab6c has been documented in: brain, testes, prostate and breast tissue (Young et al., 2010) . Functional variance between Rab6a and Rab6a' has been reported during the retrograde transport of ricin (Utskarpen et al., 2006; Liu and Storrie, 2015) . Consequently, the result of mislabelling a particular Rab6 isoform, or expressing it in an inappropriate cell type, may be a little more misleading. The result of misidentifying syntaxin proteins, such as 7 and 13, may be more drastic as misidentifying them would, in all likelihood, lead to the generation of false positives or negative conclusions in relation to subcellular distribution or trafficking.
Syntaxin13 typically catalyses vesicle fusion events between early endocytic structures, such as early endosomes (McBride et al., 1999) . Syntaxin7, also a t-soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) heavy chain, catalyses both heterotypic and homotypic fusion to late endosomes (Mullock et al., 2000; Pryor et al., 2004) . The similarity between the protein sequences of all of these molecules makes the generation of specific polyclonal antibodies challenging. The consequences of misidentifying syntaxin7
and 13 have been reported (Mullock et al., 2000) . Here additional immunodepletive steps to removed cross-reactive antibodies were taken to ensure antibody specificity (Mullock et al., 2000) .
Equivalently, monoclonal antibodies may be used to identify molecules that act as compartmental "doorkeepers", responsible for regulating fusion to, and consequently the identity of a specific intracellular compartment (Dyer et al., 2013) . This is considerably more time consuming and expensive than generating polyclonal antisera. Given the challenges and expense associated with generating polyclonal or monoclonal antibodies, specific for proteins with such a high degree of similarity, it may be easier and more accurate to express these molecules as GFP-fusion proteins. Rather than immunodetecting Rab6a and Rab6a' after siRNA knockdown, qPCR has been used (Utskarpen et al., 2006) . This approach has many limitations with regard to examining the trafficking of endocytosed cargo within the context of single-cell assays, but is certainly worth considering when using a population based cell assay. When considering the utility of a specific marker, the general and the specific need to be considered separately, given that there are nearly always exceptions to any rules of thumb.
An example might be the distribution of syntaxin6 in melanocytes. In B16F10 cells syntaxin6
has been documented to localise to late endosomes (Wade et al., 2001) . However, this localisation has been reported to be melanocyte specific and would not be expected in more generic epithelial cells.
How reliable were GFP-marker overexpression experiments when used to define a given endocytic compartment? Over a 24h timeframe, a pulse of WGA has been documented in a late endocytic compartment, which would normally contain markers including LAMP1 (or 2), lysosomal hydrolases (such as cathepsin D), or even well-characterised probes such as bovine serum albumin (BSA) or BSA-colloidal gold, subject to endolysosomal translocation (Mullock et al., 2000) . The dose of WGA (typically from 5-50 µg/mL) may also impact upon the morphology of late-endocytic compartments, however, here the dose of TxR-WGA was kept constant at 10 µg/mL as previously this had given a robust signal at a minimal concentration (of WGA) (Dyer et al., 2013) . Observing a profound co-localisation between overexpressed eGFP-Rab5a and WGA at 48h post-transfection was unexpected (figure 2: panels d-f), as previously, at this time, the internalised WGA and Rab5 might be expected to occupy late and early endocytic compartments respectively (Dyer et al., 2013) . This confusion was further underscored by the localisation of eGFP-Rab5 to an early endosomal antigen (EEA)1 positive compartment (figure 2: panels a-c). Moreover, after 24h, WGA was recorded in a LAMP positive set of vesicular structures (figure 2: panels j, k and l). These data are further contradicted by previously published data reporting eGFP-Rab5a localising to
EEA1positive structures that are typically early endocytic (i.e. on early endosomes) (Simonsen et al., 1998; Roberts et al., 1999) , yet WGA, when chased into eGFP-Rab5a overexpressing cells can be seen in dramatically expanded Rab5 positive structures (figure 2: panels d-f). Given that EEA1 not only interacts with the Rab protein, as an effector, but also inositol phosphates on the early endosomal membrane (Simonsen et al., 1998) , it is unlikely (although still possible), that the EEA1 signal was simply being redistributed by the overexpressed eGFP-Rab5a. Further, there are examples of Rab5a overexpression being separate and discreet from late endocytic markers (Dyer et al., 2013) . Confusion was compounded by the data describing the eGFP-Rab5:Q79L mutant, a GTP locked constitutively active mutant of Rab5 (Barbieri et al., 1996) . This has been documented to cause expanded vesicles that have often lost their compartmental identity as the "doorkeeper"
or Rab protein regulating fusion becomes hyperactive (Barbieri et al., 1996) . It is possible that the cells documented (panels d, e and f) were expressing a lot of Rab5a, which gave rise to a phenotype similar to that of the Rab5:Q79L mutant. Equivalently the phenotype observed may be due to an interaction between the WGA and the effects of Rab5 overexpression. This may not impact upon the assumption that the GFP tagged protein will behave in a similar way to its wild type analogue as this variance in phenotype may not be due to any alteration in protein function, but is instead due to there being much more Rab5 than would normally be found in a healthy cell. It is important to note that when using these tools, in these specific circumstances, a degree of compartment identity has been lost. Care should also be exercised when using algorithms to quantitate the degree of co-localisation. Commonly used methods to quantify co-localisation include the use of Pearson's correlation coefficient (adapted by Manders) that are quite subjective though maybe useful if applied appropriately Dunn et al., 2011) . Their usefulness is also defined by the definition of colocalisation being employed and the inferences being made. If these experiments are an attempt to discover the function of a specific protein and are attempting to resolve individual molecules, they may also be limited by the resolution of even super-resolution techniques (Dunn et al., 2011) . Figure 2 (panels j, k and l) clearly show late endocytic markers partitioned into microdomains, contained within the same vesicle. However, as there are varying degrees of co-localisation at the level of the pixel, as opposed to the vesicle, false negatives may result.
Was GFP fluorescence a robust indicator of (GFP) protein integrity? GFP stability in the presence of proteases has been reported to be high (Aoki et al., 2008) . Here the authors used a binding assay similar to the "pulldown" assay described here (figure 3: panel e) to monitor protein integrity (Aoki et al., 2008) . Figure 3 (panels a-d) documents the effects of both proteinase k and trypsin upon the fluorescence of eGFP. Previously GST-GFP was sequenced using mass spectrometry, and determined both its absorption and emission spectra in relation to eGFP determined (Pettit et al., 2014) . GST-GFP was found to exhibit maximum excitation when stimulated at 484nm with an emission peak at 492nm. This was in contrast to eGFP, which displays a maximum excitation peak at 488nm and an emission peak at 509nm (Pollock and Heim, 1999) . When either protease was used to digest GST-GFP (confirmed by Western immunoblotting (figure 3: panel d), the fluorescence spectra remained unaltered after digestion (figure 3: panels a-c). The simplest explanation for the apparent disconnect between fluorescence and GST-GFP molecular weight, was that the fluorophore located within the eGFP beta-barrel spanning helix remained partially intact after digestion. This was unexpected. However, practically, this particular phenomenon was relatively easy to circumvent if the GFP molecule was designed to contain an affinity "tag" to aid enrichment.
An example might be a 6-histidine tag or a GST "tag" as documented here (figure 3: panel e).
Can GST-GFP act as a fluid phase endocytic probe? Given the well-characterised effects of pH upon eGFP's fluorescent properties (Roberts et al., 2016) it was not surprising to note the aberrant compartmentalisation of GST-GFP post-endocytic capture. Very recently, the problem of eGFP's instability at low pH has been addressed using tandem dimer GFP variant (Ishil et al., 2007; Roberts et al., 2016) , however the problem of lysosomal proteases and methanol fixation remain. For optimal fluorescence yield, eGFP has been reported to require aldehyde fixation rather than fixation in cold methanol (Dyer et al., 2013) .
Consequently, the combination of low pH, methanol fixation and the presence of lysosomal proteases would not predispose eGFP as a robust fluid phase endolysosomal marker. This was underscored in figure 4 . Consequently, it may be more advantageous to use a transiently or stably expressed, well-characterised fluorescent protein fused to the cytosolic termini of a lysosomal trans-membrane protein as a marker such as LAMP1-RFP (Sherer et al., 2003) .
Finally, the choice of marker should also be dictated by application. Is it essential to know how many molecules are in a given compartment for optimal therapeutic effect? If so then perhaps a radiolabel is a more useful "tag" than any fluorescent molecule due to the ease of quantification. Previously, we have published a study quantifying the modulation of subcellular distribution mediated by of a series of well-defined radiolabelled poly(amidoamine) polymers after their administration in vivo . When the possibility of optimising a dose to minimise non-specific side effects is considered, the use of radioprobes remains attractive. That said radioprobes have limited use relative to fluorescent probes within the context of a single cell assay, which is also very useful for early stage evaluation of advanced drug delivery system function and subcellular distribution (Seib, et al., 2006; Richardson et al., 2008) .
Conclusion.
GFP remains a useful tool to evaluate subcellular trafficking, providing the limitations associated with its biochemistry are understood. This is true of any marker used to define a compartment. GFP's stability and fluorescent properties are not intimately connected, consequently care needs to be taken when designing experiments that might expose GFP to proteases either during in vitro cell free assays or in a cell based assay. These observations highlight some of the pitfalls working with eGFP. More generally, they also highlight the need for carefully designed experiments, a need to understand and characterise the tools you are using and the use of multiple controls in order to interrupt the data they produce in a useful and meaningful way. Is seeing believing? No, though clearly fluorescent proteins are extremely useful tools though as ever, context is everything. and TxR-BSA were documented. The localisation of a GST-GFP pulsed (as described above) to a compartment labelled with a primary monoclonal antibody specific for EEA1 and a mouse specific TxR labelled-secondary is documented (panel: (g) (GST-GFP), (h) (anti-EEA1) and (i) (merge). These micrographs were acquired using a Nikon Ti-20 microscope. The localisation of GST-GFP, pulsed and chased as before is documented (panels j, k and l). The signal from GST-GFP (panel j) is very weak; where as the signal from a pulse of TxR-WGA (panel k) is robust. A merge (panels j and k) is shown and these images were acquired using a Zeiss LSM880. The size bar represents approximately 5 microns.
